Sandoz

Sandoz

Community score

+1.80 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: Switzerland
Year added: 2023

Founded as Kern & Sandoz in 1886, the company now known as Sandoz is headquartered in Holzkirchen, Germany, and has established itself as a key player in the pharmaceutical industry. Specializing in generic drugs, biosimilars, pharmaceutical, and biotechnological active substances, Sandoz has a diversely ranged portfolio. Among the most well-known offerings are products such as Omnitrope, which is a biosimilar of somatropin, Zarxio, a biosimilar of filgrastim, and Erelzi, which stands as a biosimilar of etanercept. With a global presence, Sandoz has marked its importance in markets like the United States and Europe, addressing the demand for high-quality, affordable generics and biosimilars across these regions and other countries around the world. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View

In order to ensure strong institutions and the well-being of society, governments spend a considerable amount of the state's budget on public goods and services, which are funded by taxes paid by individuals and corporations1. On average, the stat...

19.07.2021 - Impact Analyst Emmanuel J. March 26th, 2024
10 ratings

Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. At least 10% of the household budget of over 800 million (Mn) people goes into healthcare expenditure, and 100 Mn people are pushed into extreme poverty due to unaffo...

04.11.2020 - Impact Analyst Oluwatobi O. December 14th, 2023
16 ratings

About 785 million (Mn) people do not have access to basic drinking water services1, while 2.7 billion (Bn) people are experiencing water scarcity at least a month in a year2. The world's total water demand is 4,600 Bn m3 3. Prolonged water stress ...

22.10.2020 - Impact Analyst Ardit N. December 14th, 2023
26 ratings

Research and Development (R&D) investments are essential for creating life-saving drugs and improving health security, yet numerous rare diseases still lack reliable treatments1,2. Growth hormone deficiency (GHD), a rare condition treatable with e...

12.05.2021 - Impact Analyst Toluwalope T. December 14th, 2023
22 ratings

In 2022, the adoption rate of biosimilars used for the treatment of life-threatening diseases stood at 14% across 30 global countries12. Worldwide, only 1 billion (Bn) people can access biosimilars1. Lack of medicine is a major barrier to good hea...

04.11.2020 - Impact Analyst Oluwatobi O. December 14th, 2023
20 ratings

Pharmaceuticals use a large amount of packaging, mostly made of plastic 1,2. Plastic can take up to 500 years to decompose, with the majority ending up in oceans3. Glass, another packaging material, is an inert waste that takes millions of years t...

24.08.2021 - Impact Analyst Bayonle B. December 14th, 2023
20 ratings

Drugs have been efficient in treating illnesses, diseases, and traumas throughout many decades1. Pharmaceuticals have improved the quality of life of many patients and subsequently raised the world's overall life expectancy1,2. It is estimated tha...

22.10.2020 - Impact Analyst Ardit N. December 14th, 2023
22 ratings

According to the ILO, a gender-balanced workforce is represented by a 40-60% ratio of men and women1;pxii. Women's underrepresentation limits economic development, squanders human potential, and leads to an unequal share of economic growth benefit...

02.06.2021 - Impact Analyst Oyelakin M. December 14th, 2023
16 ratings

In 2022, 3.3 billion people were employed globally1. Job creation is vital for society and the economy2. It reduces poverty and provides social protection to employees and families3. It also fosters personal development and social integration3. In...

10.09.2021 - Impact Analyst S Chandrakant Reddy S. December 14th, 2023
24 ratings